

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.55988168 |
| 2 | definitive hemopoiesis (GO:0060216) | 5.95403972 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.93659804 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.93659804 |
| 5 | negative regulation of fibrinolysis (GO:0051918) | 5.73857786 |
| 6 | regulation of protein activation cascade (GO:2000257) | 5.64214195 |
| 7 | complement activation, alternative pathway (GO:0006957) | 5.42242222 |
| 8 | regulation of complement activation (GO:0030449) | 5.40297990 |
| 9 | regulation of fibrinolysis (GO:0051917) | 5.34694209 |
| 10 | valine metabolic process (GO:0006573) | 5.23850217 |
| 11 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.85896146 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 4.84084105 |
| 13 | protein carboxylation (GO:0018214) | 4.81716019 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.81716019 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.78132799 |
| 16 | ethanol oxidation (GO:0006069) | 4.69164122 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.58640119 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.58640119 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 4.57645701 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.57645701 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 4.46701537 |
| 22 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.29671340 |
| 23 | primary alcohol catabolic process (GO:0034310) | 4.29126844 |
| 24 | viral transcription (GO:0019083) | 4.26307134 |
| 25 | phospholipid efflux (GO:0033700) | 4.26282824 |
| 26 | megakaryocyte development (GO:0035855) | 4.26238645 |
| 27 | platelet dense granule organization (GO:0060155) | 4.25252400 |
| 28 | fibrinolysis (GO:0042730) | 4.25127265 |
| 29 | DNA unwinding involved in DNA replication (GO:0006268) | 4.16522853 |
| 30 | negative regulation of protein activation cascade (GO:2000258) | 4.14660707 |
| 31 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.12777658 |
| 32 | ethanol metabolic process (GO:0006067) | 4.10058053 |
| 33 | translational termination (GO:0006415) | 4.06402743 |
| 34 | regulation of plasminogen activation (GO:0010755) | 4.04427942 |
| 35 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.04229087 |
| 36 | cellular glucuronidation (GO:0052695) | 4.03994183 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.99031200 |
| 38 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.98624212 |
| 39 | regulation of erythrocyte differentiation (GO:0045646) | 3.96729971 |
| 40 | negative regulation of lipase activity (GO:0060192) | 3.96565029 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.94999186 |
| 42 | glyoxylate metabolic process (GO:0046487) | 3.90857741 |
| 43 | intestinal cholesterol absorption (GO:0030299) | 3.90325382 |
| 44 | DNA deamination (GO:0045006) | 3.90139902 |
| 45 | desmosome organization (GO:0002934) | 3.86083250 |
| 46 | DNA strand elongation (GO:0022616) | 3.85347420 |
| 47 | plasma lipoprotein particle assembly (GO:0034377) | 3.85204446 |
| 48 | negative regulation of sterol transport (GO:0032372) | 3.83883356 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 3.83883356 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 3.83142606 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 3.83142606 |
| 52 | macromolecular complex remodeling (GO:0034367) | 3.83142606 |
| 53 | exogenous drug catabolic process (GO:0042738) | 3.82884655 |
| 54 | necroptotic process (GO:0070266) | 3.82070042 |
| 55 | cholesterol efflux (GO:0033344) | 3.80870881 |
| 56 | uronic acid metabolic process (GO:0006063) | 3.77697777 |
| 57 | glucuronate metabolic process (GO:0019585) | 3.77697777 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 3.76711235 |
| 59 | drug catabolic process (GO:0042737) | 3.74223611 |
| 60 | epoxygenase P450 pathway (GO:0019373) | 3.73642021 |
| 61 | surfactant homeostasis (GO:0043129) | 3.65251376 |
| 62 | pentose-phosphate shunt (GO:0006098) | 3.64068484 |
| 63 | protein-lipid complex assembly (GO:0065005) | 3.63503821 |
| 64 | translational elongation (GO:0006414) | 3.63349407 |
| 65 | urea metabolic process (GO:0019627) | 3.63051715 |
| 66 | phenylpropanoid metabolic process (GO:0009698) | 3.61860147 |
| 67 | negative regulation of blood coagulation (GO:0030195) | 3.61145236 |
| 68 | negative regulation of hemostasis (GO:1900047) | 3.61145236 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56450774 |
| 70 | oxaloacetate metabolic process (GO:0006107) | 3.56269452 |
| 71 | triglyceride catabolic process (GO:0019433) | 3.55726513 |
| 72 | DNA replication initiation (GO:0006270) | 3.55678019 |
| 73 | secretory granule organization (GO:0033363) | 3.53760115 |
| 74 | telomere maintenance via recombination (GO:0000722) | 3.53369380 |
| 75 | flavonoid metabolic process (GO:0009812) | 3.53016869 |
| 76 | protein activation cascade (GO:0072376) | 3.49748035 |
| 77 | negative regulation of complement activation (GO:0045916) | 3.49021770 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.48795960 |
| 79 | acylglycerol homeostasis (GO:0055090) | 3.48795960 |
| 80 | daunorubicin metabolic process (GO:0044597) | 3.48087196 |
| 81 | polyketide metabolic process (GO:0030638) | 3.48087196 |
| 82 | doxorubicin metabolic process (GO:0044598) | 3.48087196 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 3.46815106 |
| 84 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40891085 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40784360 |
| 86 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.38777111 |
| 87 | reverse cholesterol transport (GO:0043691) | 3.38641695 |
| 88 | regulation of apoptotic cell clearance (GO:2000425) | 3.37415150 |
| 89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.36878244 |
| 90 | ribosomal small subunit biogenesis (GO:0042274) | 3.36679272 |
| 91 | regulation of cholesterol homeostasis (GO:2000188) | 3.36552577 |
| 92 | negative regulation of wound healing (GO:0061045) | 3.36288793 |
| 93 | embryonic hemopoiesis (GO:0035162) | 3.35319618 |
| 94 | negative regulation of coagulation (GO:0050819) | 3.35035183 |
| 95 | bile acid metabolic process (GO:0008206) | 3.33328315 |
| 96 | tricarboxylic acid metabolic process (GO:0072350) | 3.31852644 |
| 97 | translesion synthesis (GO:0019985) | 3.29052504 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.28865554 |
| 99 | cotranslational protein targeting to membrane (GO:0006613) | 3.28835586 |
| 100 | mitotic recombination (GO:0006312) | 3.27482829 |
| 101 | chemical homeostasis within a tissue (GO:0048875) | 3.27297396 |
| 102 | protein targeting to ER (GO:0045047) | 3.26694202 |
| 103 | omega-hydroxylase P450 pathway (GO:0097267) | 3.26632425 |
| 104 | drug metabolic process (GO:0017144) | 3.26618471 |
| 105 | urea cycle (GO:0000050) | 3.26109913 |
| 106 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.23520424 |
| 107 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.22953613 |
| 108 | NADPH regeneration (GO:0006740) | 3.22574354 |
| 109 | positive regulation of granulocyte differentiation (GO:0030854) | 3.21808726 |
| 110 | complement activation (GO:0006956) | 3.21802625 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.21152273 |
| 112 | nitrogen cycle metabolic process (GO:0071941) | 3.20549055 |
| 113 | telomere maintenance via telomere lengthening (GO:0010833) | 3.18885843 |
| 114 | regulation of sequestering of triglyceride (GO:0010889) | 3.18254666 |
| 115 | thrombin receptor signaling pathway (GO:0070493) | 3.16554142 |
| 116 | glutamate metabolic process (GO:0006536) | 3.15192592 |
| 117 | bile acid biosynthetic process (GO:0006699) | 3.14628547 |
| 118 | protein-lipid complex subunit organization (GO:0071825) | 3.13197518 |
| 119 | protein localization to endoplasmic reticulum (GO:0070972) | 3.11940992 |
| 120 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.11516210 |
| 121 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.11144312 |
| 122 | acute-phase response (GO:0006953) | 3.10536239 |
| 123 | acylglycerol catabolic process (GO:0046464) | 3.10031918 |
| 124 | neutral lipid catabolic process (GO:0046461) | 3.10031918 |
| 125 | succinate metabolic process (GO:0006105) | 3.09788119 |
| 126 | negative regulation of cell aging (GO:0090344) | 3.09454481 |
| 127 | low-density lipoprotein particle remodeling (GO:0034374) | 3.09243282 |
| 128 | mast cell activation (GO:0045576) | 3.07768352 |
| 129 | negative regulation of macrophage differentiation (GO:0045650) | 3.06585161 |
| 130 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.06551073 |
| 131 | cellular protein complex disassembly (GO:0043624) | 3.04952203 |
| 132 | hemidesmosome assembly (GO:0031581) | 3.03230503 |
| 133 | gap junction assembly (GO:0016264) | 3.01020679 |
| 134 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.99750136 |
| 135 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.99347364 |
| 136 | positive regulation of blood coagulation (GO:0030194) | 2.98954754 |
| 137 | positive regulation of hemostasis (GO:1900048) | 2.98954754 |
| 138 | retinal metabolic process (GO:0042574) | 2.97377302 |
| 139 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.97289016 |
| 140 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.97289016 |
| 141 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.97054849 |
| 142 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.96740075 |
| 143 | fucose catabolic process (GO:0019317) | 2.96454622 |
| 144 | L-fucose metabolic process (GO:0042354) | 2.96454622 |
| 145 | L-fucose catabolic process (GO:0042355) | 2.96454622 |
| 146 | phospholipid homeostasis (GO:0055091) | 2.96195452 |
| 147 | response to mercury ion (GO:0046689) | 2.95833658 |
| 148 | regulation of humoral immune response (GO:0002920) | 2.95426227 |
| 149 | viral life cycle (GO:0019058) | 2.94782808 |
| 150 | T cell homeostasis (GO:0043029) | 2.93982737 |
| 151 | IMP biosynthetic process (GO:0006188) | 2.92703023 |
| 152 | primary alcohol metabolic process (GO:0034308) | 2.92442284 |
| 153 | bile acid and bile salt transport (GO:0015721) | 2.91260028 |
| 154 | alpha-linolenic acid metabolic process (GO:0036109) | 2.90458548 |
| 155 | DNA topological change (GO:0006265) | 2.89934393 |
| 156 | regulation of triglyceride catabolic process (GO:0010896) | 2.84910398 |
| 157 | aromatic amino acid family catabolic process (GO:0009074) | 2.84742883 |
| 158 | progesterone metabolic process (GO:0042448) | 2.84007618 |
| 159 | biotin metabolic process (GO:0006768) | 2.83914850 |
| 160 | lymphoid progenitor cell differentiation (GO:0002320) | 2.83671548 |
| 161 | IMP metabolic process (GO:0046040) | 2.82709250 |
| 162 | 2-oxoglutarate metabolic process (GO:0006103) | 2.80570321 |
| 163 | fatty acid beta-oxidation (GO:0006635) | 2.79506697 |
| 164 | lipoprotein metabolic process (GO:0042157) | 2.79364829 |
| 165 | blood coagulation, intrinsic pathway (GO:0007597) | 2.78986557 |
| 166 | fatty acid transmembrane transport (GO:1902001) | 2.78354073 |
| 167 | protein complex disassembly (GO:0043241) | 2.77576998 |
| 168 | positive regulation of coagulation (GO:0050820) | 2.76716347 |
| 169 | negative regulation of granulocyte differentiation (GO:0030853) | 2.76481237 |
| 170 | negative regulation of lipid transport (GO:0032369) | 2.75566595 |
| 171 | cholesterol homeostasis (GO:0042632) | 2.75263650 |
| 172 | carnitine shuttle (GO:0006853) | 2.74591834 |
| 173 | mast cell activation involved in immune response (GO:0002279) | 2.73355335 |
| 174 | mast cell degranulation (GO:0043303) | 2.73355335 |
| 175 | carnitine transmembrane transport (GO:1902603) | 2.71883921 |
| 176 | regulation of necroptotic process (GO:0060544) | 2.71643096 |
| 177 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.71455803 |
| 178 | sterol homeostasis (GO:0055092) | 2.71363500 |
| 179 | regulation of granulocyte differentiation (GO:0030852) | 2.68385778 |
| 180 | brown fat cell differentiation (GO:0050873) | 2.68126506 |
| 181 | translational initiation (GO:0006413) | 2.67159202 |
| 182 | programmed necrotic cell death (GO:0097300) | 2.66399310 |
| 183 | maturation of SSU-rRNA (GO:0030490) | 2.66348647 |
| 184 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.66235158 |
| 185 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.66149757 |
| 186 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66115268 |
| 187 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.65517689 |
| 188 | angiogenesis involved in wound healing (GO:0060055) | 2.64496001 |
| 189 | regulation of necrotic cell death (GO:0010939) | 2.60198441 |
| 190 | protein localization to kinetochore (GO:0034501) | 2.60043587 |
| 191 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.58538901 |
| 192 | lipid storage (GO:0019915) | 2.58284211 |
| 193 | oxygen transport (GO:0015671) | 2.58250402 |
| 194 | germ cell migration (GO:0008354) | 2.57884075 |
| 195 | pentose metabolic process (GO:0019321) | 2.57314939 |
| 196 | erythrocyte maturation (GO:0043249) | 2.53950803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.97831004 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.81935364 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.74865707 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.55026862 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.70323627 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.61501915 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.42351777 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.25220938 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.02013778 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.96152367 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82569298 |
| 12 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.81695851 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.74797021 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.73210501 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.66334209 |
| 16 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62179143 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61927412 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.59559528 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.53982307 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.45801783 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43505583 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.39911549 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39074870 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37680880 |
| 25 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.28501005 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24923641 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13866402 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11884937 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09144335 |
| 30 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06785877 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.06518609 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.03338713 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 2.03152173 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.02752985 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99483978 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99204626 |
| 37 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.93081201 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.92838064 |
| 39 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.91203252 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.89707907 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86876178 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.84223867 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84132221 |
| 44 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.83940987 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.83476356 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.83342305 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81154171 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.80039773 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.75730552 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.74707096 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74010722 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.73687516 |
| 53 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.71760677 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71598075 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70463079 |
| 56 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.68170718 |
| 57 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.68170718 |
| 58 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.67969428 |
| 59 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.66488744 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65445568 |
| 61 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64383950 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.64242453 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61459998 |
| 64 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.61411528 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60811636 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60636525 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.58772526 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.58357460 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57065107 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.56805704 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.56372200 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.56246830 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56114556 |
| 74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55982284 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 1.55805085 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55755926 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52497809 |
| 78 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49733390 |
| 79 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49668653 |
| 80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48843383 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47673958 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47028467 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.44672722 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44143478 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44104603 |
| 86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43851158 |
| 87 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.41226774 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38413190 |
| 89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37800560 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.37565884 |
| 91 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37220946 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36501203 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36484270 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36484270 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.35878937 |
| 96 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35830283 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.35627482 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35570687 |
| 99 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33444817 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32874273 |
| 101 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32860298 |
| 102 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32009129 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30461262 |
| 104 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30428856 |
| 105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.29928311 |
| 106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.29785542 |
| 107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29295308 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29295308 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.28444369 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 1.28306766 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28018145 |
| 112 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.27943806 |
| 113 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27807064 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26297578 |
| 115 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25293628 |
| 116 | MAF_26560356_Chip-Seq_TH1_Human | 1.24510288 |
| 117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23451673 |
| 118 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22974512 |
| 119 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.22508441 |
| 120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22053135 |
| 121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21887668 |
| 122 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.20462371 |
| 123 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19284158 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19075191 |
| 125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18721936 |
| 126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18241583 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17770669 |
| 128 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.14869324 |
| 129 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13937588 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13804088 |
| 131 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13765836 |
| 132 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13214503 |
| 133 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13159494 |
| 134 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12534979 |
| 135 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11601016 |
| 136 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11418450 |
| 137 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11277841 |
| 138 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09268692 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08912020 |
| 140 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.07919796 |
| 141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07167623 |
| 142 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05505588 |
| 143 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05237079 |
| 144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03718520 |
| 145 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.03684678 |
| 146 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02773262 |
| 147 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.02572998 |
| 148 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01546480 |
| 149 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.01428953 |
| 150 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99213306 |
| 151 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98841305 |
| 152 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98098151 |
| 153 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96722288 |
| 154 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96187207 |
| 155 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95149185 |
| 156 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94657070 |
| 157 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.94652690 |
| 158 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94313734 |
| 159 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94220544 |
| 160 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.93552732 |
| 161 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93456269 |
| 162 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93107392 |
| 163 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92757062 |
| 164 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92259137 |
| 165 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90894695 |
| 166 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90591483 |
| 167 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89202254 |
| 168 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88873684 |
| 169 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88290046 |
| 170 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.86823104 |
| 171 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86707151 |
| 172 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85933442 |
| 173 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85711412 |
| 174 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85663772 |
| 175 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85205462 |
| 176 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84591669 |
| 177 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84431502 |
| 178 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.84011557 |
| 179 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83618632 |
| 180 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83214633 |
| 181 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.82728326 |
| 182 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.82527043 |
| 183 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80345744 |
| 184 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75785910 |
| 185 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.75654497 |
| 186 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75273894 |
| 187 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.75034193 |
| 188 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74958577 |
| 189 | ATF3_27146783_Chip-Seq_COLON_Human | 0.74956118 |
| 190 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74559457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 5.03258867 |
| 2 | MP0001545_abnormal_hematopoietic_system | 3.74117111 |
| 3 | MP0005397_hematopoietic_system_phenotyp | 3.74117111 |
| 4 | MP0005670_abnormal_white_adipose | 3.24287476 |
| 5 | MP0003724_increased_susceptibility_to | 3.05168447 |
| 6 | MP0004147_increased_porphyrin_level | 2.87920400 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.78662219 |
| 8 | MP0004782_abnormal_surfactant_physiolog | 2.77240498 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.67056516 |
| 10 | MP0005275_abnormal_skin_tensile | 2.61440107 |
| 11 | MP0004272_abnormal_basement_membrane | 2.59087535 |
| 12 | MP0003195_calcinosis | 2.55565973 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.50166723 |
| 14 | MP0009840_abnormal_foam_cell | 2.45688580 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.34559681 |
| 16 | MP0003252_abnormal_bile_duct | 2.34343746 |
| 17 | MP0004130_abnormal_muscle_cell | 2.32276617 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.28393627 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.27943980 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.24028837 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.19624625 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.10915713 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.07663509 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.91814030 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.89686439 |
| 26 | MP0005451_abnormal_body_composition | 1.87458519 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.85798679 |
| 28 | MP0005365_abnormal_bile_salt | 1.84664540 |
| 29 | MP0009278_abnormal_bone_marrow | 1.84093069 |
| 30 | MP0006054_spinal_hemorrhage | 1.82800222 |
| 31 | MP0010094_abnormal_chromosome_stability | 1.79038722 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.78053974 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.77889204 |
| 34 | MP0003186_abnormal_redox_activity | 1.76496563 |
| 35 | MP0001853_heart_inflammation | 1.76050402 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.74001195 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.73082436 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.72231409 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.68213577 |
| 40 | MP0002398_abnormal_bone_marrow | 1.66700340 |
| 41 | MP0009115_abnormal_fat_cell | 1.62121601 |
| 42 | MP0002970_abnormal_white_adipose | 1.61582349 |
| 43 | MP0002796_impaired_skin_barrier | 1.59190079 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.58175747 |
| 45 | MP0000751_myopathy | 1.57464077 |
| 46 | MP0008057_abnormal_DNA_replication | 1.54258590 |
| 47 | MP0005408_hypopigmentation | 1.52442660 |
| 48 | MP0005332_abnormal_amino_acid | 1.50901737 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.46244765 |
| 50 | MP0002006_tumorigenesis | 1.45518180 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.42314659 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.40983307 |
| 53 | MP0002971_abnormal_brown_adipose | 1.40017301 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.39692900 |
| 55 | MP0000343_altered_response_to | 1.39598051 |
| 56 | MP0000490_abnormal_crypts_of | 1.39551187 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.37331967 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.35519935 |
| 59 | MP0000566_synostosis | 1.35021210 |
| 60 | MP0009785_altered_susceptibility_to | 1.34304661 |
| 61 | MP0003941_abnormal_skin_development | 1.34059267 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.33204968 |
| 63 | MP0005023_abnormal_wound_healing | 1.32638790 |
| 64 | MP0005535_abnormal_body_temperature | 1.32333876 |
| 65 | MP0002722_abnormal_immune_system | 1.29844704 |
| 66 | MP0006138_congestive_heart_failure | 1.29362439 |
| 67 | MP0005025_abnormal_response_to | 1.28226508 |
| 68 | MP0000749_muscle_degeneration | 1.26427189 |
| 69 | MP0000609_abnormal_liver_physiology | 1.25793136 |
| 70 | MP0005334_abnormal_fat_pad | 1.25088233 |
| 71 | MP0004087_abnormal_muscle_fiber | 1.24502894 |
| 72 | MP0002429_abnormal_blood_cell | 1.23429424 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.22899979 |
| 74 | MP0001915_intracranial_hemorrhage | 1.22081724 |
| 75 | MP0008775_abnormal_heart_ventricle | 1.21826131 |
| 76 | MP0005671_abnormal_response_to | 1.21291209 |
| 77 | MP0001764_abnormal_homeostasis | 1.20625192 |
| 78 | MP0000685_abnormal_immune_system | 1.20458762 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19228764 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 1.18494199 |
| 81 | MP0009384_cardiac_valve_regurgitation | 1.18367784 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 1.18342441 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.17945485 |
| 84 | MP0000716_abnormal_immune_system | 1.17120792 |
| 85 | MP0001958_emphysema | 1.17117621 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 1.16637953 |
| 87 | MP0002060_abnormal_skin_morphology | 1.16151922 |
| 88 | MP0004858_abnormal_nervous_system | 1.13916492 |
| 89 | MP0003828_pulmonary_edema | 1.13415038 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 1.11772503 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.11219136 |
| 92 | MP0002419_abnormal_innate_immunity | 1.10673622 |
| 93 | MP0005409_darkened_coat_color | 1.09933365 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 1.08806158 |
| 95 | MP0001819_abnormal_immune_cell | 1.08214157 |
| 96 | MP0000747_muscle_weakness | 1.07634417 |
| 97 | MP0005164_abnormal_response_to | 1.06630337 |
| 98 | MP0008007_abnormal_cellular_replicative | 1.06496519 |
| 99 | MP0003111_abnormal_nucleus_morphology | 1.06441118 |
| 100 | MP0000579_abnormal_nail_morphology | 1.06435088 |
| 101 | MP0001800_abnormal_humoral_immune | 1.06272424 |
| 102 | MP0002269_muscular_atrophy | 1.05747036 |
| 103 | MP0008469_abnormal_protein_level | 1.03999293 |
| 104 | MP0003279_aneurysm | 1.03509196 |
| 105 | MP0004233_abnormal_muscle_weight | 1.03108694 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02188926 |
| 107 | MP0002019_abnormal_tumor_incidence | 1.02020221 |
| 108 | MP0002102_abnormal_ear_morphology | 1.01848564 |
| 109 | MP0002876_abnormal_thyroid_physiology | 1.01610885 |
| 110 | MP0009697_abnormal_copulation | 1.01259971 |
| 111 | MP0004145_abnormal_muscle_electrophysio | 1.00809653 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 1.00240613 |
| 113 | MP0002132_abnormal_respiratory_system | 0.99680110 |
| 114 | MP0004084_abnormal_cardiac_muscle | 0.98405600 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.98222049 |
| 116 | MP0003959_abnormal_lean_body | 0.97166027 |
| 117 | MP0002452_abnormal_antigen_presenting | 0.96824171 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.96355074 |
| 119 | MP0002723_abnormal_immune_serum | 0.95742610 |
| 120 | MP0003077_abnormal_cell_cycle | 0.95416196 |
| 121 | MP0010630_abnormal_cardiac_muscle | 0.95379478 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.94732451 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.93824596 |
| 124 | MP0004883_abnormal_blood_vessel | 0.93009126 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.92655382 |
| 126 | MP0005647_abnormal_sex_gland | 0.92514858 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.92491363 |
| 128 | MP0004019_abnormal_vitamin_homeostasis | 0.92322087 |
| 129 | MP0001873_stomach_inflammation | 0.92304041 |
| 130 | MP0002095_abnormal_skin_pigmentation | 0.92218994 |
| 131 | MP0000003_abnormal_adipose_tissue | 0.91729572 |
| 132 | MP0003866_abnormal_defecation | 0.91723273 |
| 133 | MP0000467_abnormal_esophagus_morphology | 0.90920175 |
| 134 | MP0000759_abnormal_skeletal_muscle | 0.89941726 |
| 135 | MP0009763_increased_sensitivity_to | 0.89905787 |
| 136 | MP0005360_urolithiasis | 0.89119111 |
| 137 | MP0002108_abnormal_muscle_morphology | 0.88244104 |
| 138 | MP0000598_abnormal_liver_morphology | 0.86626677 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.85981329 |
| 140 | MP0000858_altered_metastatic_potential | 0.85759586 |
| 141 | MP0005000_abnormal_immune_tolerance | 0.85694552 |
| 142 | MP0002106_abnormal_muscle_physiology | 0.85204315 |
| 143 | MP0003646_muscle_fatigue | 0.82086714 |
| 144 | MP0003690_abnormal_glial_cell | 0.81832523 |
| 145 | MP0002405_respiratory_system_inflammati | 0.81449357 |
| 146 | MP0005501_abnormal_skin_physiology | 0.81365719 |
| 147 | MP0000750_abnormal_muscle_regeneration | 0.80920600 |
| 148 | MP0000733_abnormal_muscle_development | 0.80514032 |
| 149 | MP0005248_abnormal_Harderian_gland | 0.80323018 |
| 150 | MP0001845_abnormal_inflammatory_respons | 0.80145282 |
| 151 | MP0005369_muscle_phenotype | 0.79760674 |
| 152 | MP0004264_abnormal_extraembryonic_tissu | 0.78530825 |
| 153 | MP0005452_abnormal_adipose_tissue | 0.78277746 |
| 154 | MP0010678_abnormal_skin_adnexa | 0.78266165 |
| 155 | MP0005076_abnormal_cell_differentiation | 0.77907372 |
| 156 | MP0001661_extended_life_span | 0.77502154 |
| 157 | MP0002837_dystrophic_cardiac_calcinosis | 0.75664406 |
| 158 | MP0009379_abnormal_foot_pigmentation | 0.74878188 |
| 159 | MP0005330_cardiomyopathy | 0.74676959 |
| 160 | MP0003300_gastrointestinal_ulcer | 0.74662895 |
| 161 | MP0003693_abnormal_embryo_hatching | 0.74465118 |
| 162 | MP0005620_abnormal_muscle_contractility | 0.72406140 |
| 163 | MP0003868_abnormal_feces_composition | 0.71385148 |
| 164 | MP0009333_abnormal_splenocyte_physiolog | 0.71188043 |
| 165 | MP0000767_abnormal_smooth_muscle | 0.70249394 |
| 166 | MP0002972_abnormal_cardiac_muscle | 0.69983414 |
| 167 | MP0003091_abnormal_cell_migration | 0.69769341 |
| 168 | MP0005167_abnormal_blood-brain_barrier | 0.68272353 |
| 169 | MP0000383_abnormal_hair_follicle | 0.68093228 |
| 170 | MP0000249_abnormal_blood_vessel | 0.66036119 |
| 171 | MP0002128_abnormal_blood_circulation | 0.65671917 |
| 172 | MP0000537_abnormal_urethra_morphology | 0.65593425 |
| 173 | MP0001216_abnormal_epidermal_layer | 0.64154356 |
| 174 | MP0005187_abnormal_penis_morphology | 0.63252278 |
| 175 | MP0001851_eye_inflammation | 0.62987956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.53992502 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37428609 |
| 3 | Complement deficiency (HP:0004431) | 5.90568122 |
| 4 | Aplastic anemia (HP:0001915) | 5.30757563 |
| 5 | Prolonged bleeding time (HP:0003010) | 5.13403476 |
| 6 | Petechiae (HP:0000967) | 5.11887289 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 5.11083130 |
| 8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.83192775 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.80976578 |
| 10 | Abnormality of complement system (HP:0005339) | 4.68066850 |
| 11 | Chronic otitis media (HP:0000389) | 4.64064932 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.52497299 |
| 13 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.26290521 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.17911972 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.01016917 |
| 16 | Muscle fiber inclusion bodies (HP:0100299) | 3.94004680 |
| 17 | Joint hemorrhage (HP:0005261) | 3.91956253 |
| 18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.89448972 |
| 19 | Nemaline bodies (HP:0003798) | 3.84909754 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79076979 |
| 21 | Exercise-induced myalgia (HP:0003738) | 3.57364845 |
| 22 | Abnormal platelet function (HP:0011869) | 3.57070219 |
| 23 | Impaired platelet aggregation (HP:0003540) | 3.57070219 |
| 24 | Purpura (HP:0000979) | 3.52841482 |
| 25 | Hypolipoproteinemia (HP:0010981) | 3.47656300 |
| 26 | Abnormal platelet volume (HP:0011876) | 3.45320608 |
| 27 | Glomerulonephritis (HP:0000099) | 3.43954937 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.34633548 |
| 29 | Hypertriglyceridemia (HP:0002155) | 3.28153240 |
| 30 | Increased mean platelet volume (HP:0011877) | 3.25577011 |
| 31 | Epistaxis (HP:0000421) | 3.23003690 |
| 32 | IgM deficiency (HP:0002850) | 3.18221602 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.11282428 |
| 34 | Xanthomatosis (HP:0000991) | 3.10874723 |
| 35 | Thrombocytosis (HP:0001894) | 3.09076077 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 3.05640568 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.02785389 |
| 38 | Increased muscle lipid content (HP:0009058) | 2.95143674 |
| 39 | Acute myeloid leukemia (HP:0004808) | 2.94161240 |
| 40 | Mitral stenosis (HP:0001718) | 2.93166892 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.89914580 |
| 42 | Reticulocytopenia (HP:0001896) | 2.89888316 |
| 43 | Spontaneous abortion (HP:0005268) | 2.89101753 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 2.87444517 |
| 45 | Pallor (HP:0000980) | 2.84824146 |
| 46 | Acanthocytosis (HP:0001927) | 2.79735334 |
| 47 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79525643 |
| 48 | Recurrent viral infections (HP:0004429) | 2.78838179 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.78826952 |
| 50 | Hypoplasia of the thymus (HP:0000778) | 2.75134393 |
| 51 | Muscle fiber atrophy (HP:0100295) | 2.75129717 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.72644260 |
| 53 | Gingival bleeding (HP:0000225) | 2.70645028 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.66175518 |
| 55 | Nasal polyposis (HP:0100582) | 2.65573568 |
| 56 | Arterial tortuosity (HP:0005116) | 2.64666939 |
| 57 | Nephritis (HP:0000123) | 2.62681347 |
| 58 | Reduced antithrombin III activity (HP:0001976) | 2.60701605 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.59067863 |
| 60 | Vascular calcification (HP:0004934) | 2.58090194 |
| 61 | Type 2 muscle fiber atrophy (HP:0003554) | 2.55600825 |
| 62 | Fat malabsorption (HP:0002630) | 2.54040126 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.52862252 |
| 64 | Aortic dissection (HP:0002647) | 2.49940738 |
| 65 | Neoplasm of head and neck (HP:0012288) | 2.41966941 |
| 66 | Esophageal neoplasm (HP:0100751) | 2.41966941 |
| 67 | Alopecia of scalp (HP:0002293) | 2.41627046 |
| 68 | Atrophic scars (HP:0001075) | 2.40720787 |
| 69 | Large hands (HP:0001176) | 2.39852777 |
| 70 | Vascular tortuosity (HP:0004948) | 2.39572634 |
| 71 | Bone cyst (HP:0012062) | 2.36866493 |
| 72 | Papilledema (HP:0001085) | 2.36499619 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36213449 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.36213449 |
| 75 | Hyporeflexia of lower limbs (HP:0002600) | 2.36144482 |
| 76 | Acute lymphatic leukemia (HP:0006721) | 2.34258853 |
| 77 | Recurrent bronchitis (HP:0002837) | 2.33792923 |
| 78 | Hepatic necrosis (HP:0002605) | 2.33210835 |
| 79 | Menorrhagia (HP:0000132) | 2.32012293 |
| 80 | Thyroid-stimulating hormone excess (HP:0002925) | 2.31559509 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.31449454 |
| 82 | Abnormality of the nasal septum (HP:0000419) | 2.28531202 |
| 83 | Poikilocytosis (HP:0004447) | 2.28529581 |
| 84 | Abnormality of the intrinsic pathway (HP:0010989) | 2.28462715 |
| 85 | Hyperammonemia (HP:0001987) | 2.28174348 |
| 86 | Hyperglycinuria (HP:0003108) | 2.27675768 |
| 87 | Protrusio acetabuli (HP:0003179) | 2.27415867 |
| 88 | Interstitial pulmonary disease (HP:0006530) | 2.26821177 |
| 89 | Oligomenorrhea (HP:0000876) | 2.25630195 |
| 90 | Abnormality of the fingertips (HP:0001211) | 2.23689532 |
| 91 | Type I transferrin isoform profile (HP:0003642) | 2.18950446 |
| 92 | Abnormality of carpal bone ossification (HP:0006257) | 2.18811429 |
| 93 | Abnormal spermatogenesis (HP:0008669) | 2.18339150 |
| 94 | Distal arthrogryposis (HP:0005684) | 2.17111780 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 2.14984677 |
| 96 | Pancytopenia (HP:0001876) | 2.14560877 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.12957952 |
| 98 | Abnormality of lateral ventricle (HP:0030047) | 2.11744036 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11258519 |
| 100 | Brushfield spots (HP:0001088) | 2.10665593 |
| 101 | Myelodysplasia (HP:0002863) | 2.10197092 |
| 102 | Increased connective tissue (HP:0009025) | 2.09783361 |
| 103 | Amaurosis fugax (HP:0100576) | 2.08939578 |
| 104 | Exercise-induced muscle cramps (HP:0003710) | 2.07222578 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06965356 |
| 106 | Osteolytic defects of the hand bones (HP:0009699) | 2.06965356 |
| 107 | Limb hypertonia (HP:0002509) | 2.06674532 |
| 108 | Recurrent fungal infections (HP:0002841) | 2.06430901 |
| 109 | Myocardial infarction (HP:0001658) | 2.06176495 |
| 110 | Aortic aneurysm (HP:0004942) | 2.06010522 |
| 111 | Abnormality of secondary sexual hair (HP:0009888) | 2.05586802 |
| 112 | Abnormality of the axillary hair (HP:0100134) | 2.05586802 |
| 113 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04693261 |
| 114 | Flat acetabular roof (HP:0003180) | 2.02777658 |
| 115 | Round ear (HP:0100830) | 2.00626429 |
| 116 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00523265 |
| 117 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00523265 |
| 118 | Abnormal protein glycosylation (HP:0012346) | 2.00523265 |
| 119 | Abnormal glycosylation (HP:0012345) | 2.00523265 |
| 120 | Epidermoid cyst (HP:0200040) | 1.99145010 |
| 121 | Birth length less than 3rd percentile (HP:0003561) | 1.98891016 |
| 122 | Rhabdomyolysis (HP:0003201) | 1.98803080 |
| 123 | Osteomalacia (HP:0002749) | 1.98763123 |
| 124 | Macrocytic anemia (HP:0001972) | 1.98644852 |
| 125 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98589933 |
| 126 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98149243 |
| 127 | Hepatocellular necrosis (HP:0001404) | 1.97454386 |
| 128 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.96583377 |
| 129 | Abnormality of glycine metabolism (HP:0010895) | 1.96583377 |
| 130 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.95316285 |
| 131 | Fragile skin (HP:0001030) | 1.94335682 |
| 132 | Aplasia involving bones of the extremities (HP:0009825) | 1.94065820 |
| 133 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.94065820 |
| 134 | Aplasia of the phalanges of the hand (HP:0009802) | 1.94065820 |
| 135 | Abnormality of the prostate (HP:0008775) | 1.93942500 |
| 136 | Cellulitis (HP:0100658) | 1.93231914 |
| 137 | Fair hair (HP:0002286) | 1.92713821 |
| 138 | Hyperbilirubinemia (HP:0002904) | 1.92598904 |
| 139 | Increased serum ferritin (HP:0003281) | 1.91315377 |
| 140 | Advanced eruption of teeth (HP:0006288) | 1.90819711 |
| 141 | Easy fatigability (HP:0003388) | 1.89672126 |
| 142 | Cerebral aneurysm (HP:0004944) | 1.89509319 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.89275072 |
| 144 | Back pain (HP:0003418) | 1.88793321 |
| 145 | Hydroxyprolinuria (HP:0003080) | 1.88126903 |
| 146 | Abnormality of proline metabolism (HP:0010907) | 1.88126903 |
| 147 | Abnormal delivery (HP:0001787) | 1.88082845 |
| 148 | Steatorrhea (HP:0002570) | 1.87536463 |
| 149 | Abnormal ossification of hand bones (HP:0005921) | 1.86492698 |
| 150 | Ragged-red muscle fibers (HP:0003200) | 1.86027680 |
| 151 | Absent phalangeal crease (HP:0006109) | 1.85313693 |
| 152 | Hypoglycemic coma (HP:0001325) | 1.84858091 |
| 153 | Abnormality of reticulocytes (HP:0004312) | 1.83806755 |
| 154 | Hepatocellular carcinoma (HP:0001402) | 1.83771117 |
| 155 | Rickets (HP:0002748) | 1.83257138 |
| 156 | Ulnar deviation of the wrist (HP:0003049) | 1.81995903 |
| 157 | Facial diplegia (HP:0001349) | 1.81241025 |
| 158 | Premature rupture of membranes (HP:0001788) | 1.81084173 |
| 159 | Hyperacusis (HP:0010780) | 1.80633331 |
| 160 | Hypothermia (HP:0002045) | 1.80165795 |
| 161 | Nausea (HP:0002018) | 1.79993448 |
| 162 | Abnormality of the Achilles tendon (HP:0005109) | 1.79101858 |
| 163 | Plantar hyperkeratosis (HP:0007556) | 1.78972735 |
| 164 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.77990256 |
| 165 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.77990256 |
| 166 | EMG: myopathic abnormalities (HP:0003458) | 1.76873988 |
| 167 | High pitched voice (HP:0001620) | 1.76280700 |
| 168 | Popliteal pterygium (HP:0009756) | 1.76217865 |
| 169 | Abnormality of T cells (HP:0002843) | 1.76023913 |
| 170 | Ketosis (HP:0001946) | 1.75444404 |
| 171 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.74598320 |
| 172 | Elevated hepatic transaminases (HP:0002910) | 1.73816383 |
| 173 | Myopathic facies (HP:0002058) | 1.73792976 |
| 174 | Malnutrition (HP:0004395) | 1.72662782 |
| 175 | Muscle fiber splitting (HP:0003555) | 1.71456036 |
| 176 | Multiple enchondromatosis (HP:0005701) | 1.70957138 |
| 177 | Ulnar bowing (HP:0003031) | 1.70872109 |
| 178 | Pterygium (HP:0001059) | 1.70741344 |
| 179 | Hypotrichosis (HP:0001006) | 1.70332613 |
| 180 | Myositis (HP:0100614) | 1.70075979 |
| 181 | Skin nodule (HP:0200036) | 1.68802802 |
| 182 | Short middle phalanx of the 5th finger (HP:0004220) | 1.68290110 |
| 183 | Intrahepatic cholestasis (HP:0001406) | 1.68238656 |
| 184 | Azoospermia (HP:0000027) | 1.68230014 |
| 185 | Atrioventricular block (HP:0001678) | 1.68148029 |
| 186 | Gastrointestinal inflammation (HP:0004386) | 1.68127811 |
| 187 | Abnormality of nucleobase metabolism (HP:0010932) | 1.67938560 |
| 188 | Myoglobinuria (HP:0002913) | 1.67062575 |
| 189 | Palpitations (HP:0001962) | 1.66687476 |
| 190 | Insulin resistance (HP:0000855) | 1.66681451 |
| 191 | Palmoplantar hyperkeratosis (HP:0000972) | 1.64684768 |
| 192 | Neck muscle weakness (HP:0000467) | 1.63806038 |
| 193 | Abnormal hand bone ossification (HP:0010660) | 1.63735844 |
| 194 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63446986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.50570034 |
| 2 | OBSCN | 3.92045312 |
| 3 | KIT | 3.87486570 |
| 4 | EEF2K | 3.77133620 |
| 5 | STK16 | 2.88787338 |
| 6 | ERN1 | 2.82501399 |
| 7 | FGFR4 | 2.68942918 |
| 8 | MET | 2.65372741 |
| 9 | NME2 | 2.54711618 |
| 10 | FLT3 | 2.48129854 |
| 11 | EPHA2 | 2.47726299 |
| 12 | AKT3 | 2.43400228 |
| 13 | LATS1 | 2.40926771 |
| 14 | WEE1 | 2.38526853 |
| 15 | PIM2 | 2.34587018 |
| 16 | MAP4K1 | 2.21510041 |
| 17 | PKN2 | 2.19116257 |
| 18 | BCKDK | 2.17866283 |
| 19 | PHKG2 | 2.08712206 |
| 20 | PHKG1 | 2.08712206 |
| 21 | TNIK | 2.05714124 |
| 22 | MYLK | 2.05168457 |
| 23 | TAOK3 | 2.01397400 |
| 24 | MATK | 1.96997558 |
| 25 | MAPKAPK5 | 1.90858292 |
| 26 | RPS6KB2 | 1.90500782 |
| 27 | CDC7 | 1.90407867 |
| 28 | BTK | 1.87958216 |
| 29 | LMTK2 | 1.83858575 |
| 30 | LATS2 | 1.80892028 |
| 31 | ICK | 1.78236722 |
| 32 | BRSK2 | 1.68156990 |
| 33 | PIK3CA | 1.64743098 |
| 34 | TEC | 1.64432653 |
| 35 | TRIB3 | 1.64288000 |
| 36 | SCYL2 | 1.61115671 |
| 37 | MAPKAPK3 | 1.48818512 |
| 38 | FER | 1.43146800 |
| 39 | PDK2 | 1.41380227 |
| 40 | JAK3 | 1.41037124 |
| 41 | TIE1 | 1.38285823 |
| 42 | CSF1R | 1.38074051 |
| 43 | ERBB4 | 1.38010664 |
| 44 | TGFBR1 | 1.34787353 |
| 45 | MAP3K6 | 1.33784039 |
| 46 | NEK9 | 1.32660093 |
| 47 | CDK19 | 1.26779151 |
| 48 | MAPK7 | 1.24879570 |
| 49 | CAMK1D | 1.23245451 |
| 50 | MAP2K3 | 1.21288555 |
| 51 | MAP3K12 | 1.17775482 |
| 52 | PIK3CG | 1.15273580 |
| 53 | VRK1 | 1.14441654 |
| 54 | CDK4 | 1.14383029 |
| 55 | ATR | 1.11813122 |
| 56 | SYK | 1.11208420 |
| 57 | EPHA3 | 1.08197243 |
| 58 | MKNK1 | 1.07267192 |
| 59 | TGFBR2 | 1.07094903 |
| 60 | ZAP70 | 1.07080254 |
| 61 | PDGFRB | 1.06599373 |
| 62 | RAF1 | 1.06112572 |
| 63 | LRRK2 | 1.04375432 |
| 64 | STK38L | 1.01837478 |
| 65 | MAPK4 | 1.01367078 |
| 66 | PIM1 | 1.00496105 |
| 67 | CDK7 | 0.99250211 |
| 68 | DAPK1 | 0.98528248 |
| 69 | STK39 | 0.98100649 |
| 70 | STK24 | 0.96229758 |
| 71 | MAPK12 | 0.95336585 |
| 72 | TSSK6 | 0.94572902 |
| 73 | PTK2 | 0.94441407 |
| 74 | MTOR | 0.93861345 |
| 75 | TBK1 | 0.93761407 |
| 76 | SIK1 | 0.91283978 |
| 77 | FGFR1 | 0.90678261 |
| 78 | FES | 0.90548583 |
| 79 | GSK3A | 0.90533913 |
| 80 | JAK2 | 0.87198422 |
| 81 | CDK6 | 0.87152773 |
| 82 | PAK4 | 0.86844995 |
| 83 | MAP3K2 | 0.83473241 |
| 84 | TESK1 | 0.82450434 |
| 85 | STK4 | 0.82372448 |
| 86 | EPHB2 | 0.80868129 |
| 87 | KDR | 0.80737015 |
| 88 | TRPM7 | 0.80467331 |
| 89 | TYK2 | 0.77553208 |
| 90 | MAPK11 | 0.76958533 |
| 91 | DYRK3 | 0.76325384 |
| 92 | PRKG2 | 0.74712074 |
| 93 | CAMK1 | 0.74657653 |
| 94 | PBK | 0.74514774 |
| 95 | STK3 | 0.74352838 |
| 96 | IRAK4 | 0.73786455 |
| 97 | PAK2 | 0.73652898 |
| 98 | NLK | 0.73642639 |
| 99 | PRKAA2 | 0.73540389 |
| 100 | ILK | 0.72637832 |
| 101 | CDC42BPA | 0.71513277 |
| 102 | EPHB1 | 0.70904452 |
| 103 | DDR2 | 0.70422776 |
| 104 | MELK | 0.69398294 |
| 105 | NEK2 | 0.68889285 |
| 106 | PASK | 0.67897675 |
| 107 | PRKAA1 | 0.67497484 |
| 108 | LYN | 0.67326309 |
| 109 | GRK6 | 0.66320501 |
| 110 | CCNB1 | 0.64253362 |
| 111 | TAOK1 | 0.63708386 |
| 112 | TXK | 0.62109716 |
| 113 | MAP3K7 | 0.59720856 |
| 114 | ARAF | 0.59343635 |
| 115 | PDPK1 | 0.58199435 |
| 116 | TTN | 0.57316635 |
| 117 | SRPK1 | 0.57135794 |
| 118 | RET | 0.56968424 |
| 119 | TNK2 | 0.56313180 |
| 120 | MAP3K9 | 0.56144956 |
| 121 | SGK3 | 0.55383384 |
| 122 | CAMK2G | 0.54039333 |
| 123 | FGFR3 | 0.52738135 |
| 124 | MUSK | 0.52361224 |
| 125 | RPS6KA6 | 0.52042489 |
| 126 | RIPK1 | 0.51994266 |
| 127 | WNK1 | 0.51506372 |
| 128 | LCK | 0.51285009 |
| 129 | CAMK1G | 0.51187639 |
| 130 | RPS6KB1 | 0.50820570 |
| 131 | ALK | 0.50808129 |
| 132 | PRKD3 | 0.50720600 |
| 133 | PRKCE | 0.50667401 |
| 134 | AKT2 | 0.50436807 |
| 135 | CDK12 | 0.50380161 |
| 136 | MOS | 0.48940616 |
| 137 | IGF1R | 0.47349744 |
| 138 | IRAK3 | 0.46155371 |
| 139 | STK38 | 0.45907215 |
| 140 | BMX | 0.45398681 |
| 141 | PTK6 | 0.45381456 |
| 142 | NTRK1 | 0.44116769 |
| 143 | FRK | 0.43758993 |
| 144 | PDGFRA | 0.43408313 |
| 145 | PRPF4B | 0.42750799 |
| 146 | BLK | 0.42635393 |
| 147 | RPS6KL1 | 0.42554307 |
| 148 | RPS6KC1 | 0.42554307 |
| 149 | MAP3K11 | 0.42098852 |
| 150 | BRSK1 | 0.41705277 |
| 151 | PRKACG | 0.41561799 |
| 152 | RPS6KA2 | 0.41406272 |
| 153 | WNK4 | 0.41322997 |
| 154 | AURKB | 0.41174236 |
| 155 | SGK2 | 0.40355657 |
| 156 | MAPK3 | 0.40093999 |
| 157 | DMPK | 0.39828212 |
| 158 | PTK2B | 0.39793775 |
| 159 | IKBKE | 0.39777674 |
| 160 | IKBKB | 0.39370245 |
| 161 | MAP2K4 | 0.38289590 |
| 162 | JAK1 | 0.37938446 |
| 163 | MKNK2 | 0.37808597 |
| 164 | SGK223 | 0.37530181 |
| 165 | SGK494 | 0.37530181 |
| 166 | PDK3 | 0.36817673 |
| 167 | LIMK1 | 0.36236126 |
| 168 | MAP3K1 | 0.35650180 |
| 169 | MAP3K3 | 0.34567462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.96106612 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31575382 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.24855807 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.07122776 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.91433558 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.86904444 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.58626088 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57561467 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 2.53429699 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.48109704 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.34115831 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.27370469 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23934017 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15550794 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.10535556 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.09715594 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88826079 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85121272 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.83068188 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.80740732 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78788004 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78264041 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.64926416 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.61740514 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61214170 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58463398 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57370366 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54207616 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.52839127 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51654235 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45874407 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45516354 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.40311528 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.39209934 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.37715998 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37037093 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35542637 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33417344 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31514393 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.29971816 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.25360083 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.21733087 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19422022 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19303634 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18046480 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17317074 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16558497 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16131463 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15140387 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13499280 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11116979 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07987793 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07899965 |
| 54 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07502596 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06306209 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05662822 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04131402 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03066882 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02930889 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02761745 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02171394 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00713186 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98019296 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.97758053 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96358750 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93036437 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.92731322 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.90761492 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.90504643 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88708788 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84358862 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83831879 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.83405352 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81948159 |
| 75 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80588026 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78927835 |
| 77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78393042 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.78064965 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75355291 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74222285 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73604650 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71682286 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.71271188 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70777670 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68541482 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67738406 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67617354 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66853745 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66453821 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66107779 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64920129 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64731250 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64035188 |
| 94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63879816 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63005171 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62977259 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62928778 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.61630285 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61235867 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58960590 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58857042 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.58718318 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.58479657 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58246790 |
| 105 | RNA transport_Homo sapiens_hsa03013 | 0.58145434 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.57350604 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.57003148 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.56223106 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56169090 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56097903 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.55706734 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.54497402 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54204730 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52645754 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50466128 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47997277 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47411993 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46076284 |
| 119 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45227646 |
| 120 | RNA polymerase_Homo sapiens_hsa03020 | 0.44810754 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44776223 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.44219215 |
| 123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42156280 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42059263 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42035489 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41004149 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40318979 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40145112 |
| 129 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40074297 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39824157 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38873655 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37640258 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36660589 |
| 134 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36504914 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36420960 |
| 136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36237492 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36003665 |
| 138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34690449 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.34127440 |
| 140 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33529390 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33252667 |
| 142 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32740610 |
| 143 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31361830 |
| 144 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.27698529 |
| 145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23072525 |
| 146 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20471886 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17839612 |
| 148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16810526 |
| 149 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.15374504 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13082483 |
| 151 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11100043 |

